These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comparison of the antihypertensive effect of a double dose of metoprolol versus the addition of hydrochlorothiazide to metoprolol. Smilde JG. Eur J Clin Pharmacol; 1983; 25(5):581-3. PubMed ID: 6363096 [Abstract] [Full Text] [Related]
24. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa. Malini PL, Strocchi E, Ambrosioni E, Magnani B. Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071 [Abstract] [Full Text] [Related]
25. Influence of the decarboxylase inhibitor benserazide on the antihypertensive effect and metabolism of alpha-methyldopa in patients with essential hypertension. Planz G, Gierlichs HW, Hawlina A, Planz R, Stephany W, Rahn KH. Eur J Clin Pharmacol; 1977 Dec 02; 12(4):241-5. PubMed ID: 338308 [No Abstract] [Full Text] [Related]
32. [Comparison of exercise tolerance in hypertensive patients treated with atenolol and methyldopa]. Ambrosioni E, Costa FV, Agosta R, Magnani B. G Clin Med; 1979 Aug 02; 60(8):676-83. PubMed ID: 398306 [No Abstract] [Full Text] [Related]
33. [Protection of the hypertensive patient: comparative atenolol-metoprolol study]. Mazzari M, Coppola E, Montenero AS, Schiavoni G, Domenichelli B, Mongiardo R, Pennestrì F. Cardiologia; 1982 Aug 02; 27(8):753-63. PubMed ID: 6892449 [No Abstract] [Full Text] [Related]
34. Exercise blood pressure and heart rate reduction 24 and 3 hours after drug intake in hypertensive patients following 4 weeks of treatment with bisoprolol and metoprolol: a randomized multicentre double-blind study (BISOMET). Haasis R, Bethge H. Eur Heart J; 1987 Dec 02; 8 Suppl M():103-13. PubMed ID: 2967183 [Abstract] [Full Text] [Related]
35. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension. Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S. Clin Ther; 1985 Dec 02; 7(2):199-204. PubMed ID: 3886142 [Abstract] [Full Text] [Related]
36. Comparison of the duration of antihypertensive action of atenolol and metoprolol over a 24-hour period. Crowe PF, Ferguson RJ. Curr Med Res Opin; 1985 Dec 02; 9(7):431-5. PubMed ID: 4028805 [Abstract] [Full Text] [Related]
37. Effects of felodipine on rest and exercise heart rate and blood pressure in hypertensive patients. Lorimer AR, McAlpine HM, Rae AP, Simpson IA, Barbour MP, Forret EA, Hill TW, Lawrie TD. Drugs; 1985 Dec 02; 29 Suppl 2():154-7. PubMed ID: 3886358 [No Abstract] [Full Text] [Related]
38. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM. Circulation; 1985 Sep 02; 72(3):536-46. PubMed ID: 3893793 [Abstract] [Full Text] [Related]
39. Control of hypertension in elderly patients with felodipine and metoprolol: a double-blind, placebo-controlled clinical trial. Freeling P, Davis RH, Goves JR, Burton RH, Orme-Smith EA. Br J Clin Pharmacol; 1987 Oct 02; 24(4):459-64. PubMed ID: 3318897 [Abstract] [Full Text] [Related]
40. Effects of chronic antihypertensive treatment with ketanserin versus metoprolol on blood pressure and large arteries' compliance in humans: a cross-over double-blind study. De Luca N, Rosiello G, Crispino M, Volpe M, Galletti P, Buzzetti G, Trimarco B. J Clin Pharmacol; 1988 Apr 02; 28(4):332-8. PubMed ID: 3292598 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]